Clinical Nutrition Market Report 2026

Clinical Nutrition Market Overview

• Clinical Nutrition market size has reached to $64.37 billion in 2025 • Expected to grow to $102.42 billion in 2030 at a compound annual growth rate (CAGR) of 9.8% • Growth Driver: Rising Geriatric Population Boosts Growth Of The Clinical Nutrition Market • Market Trend: Technological Advancements in the Clinical Nutrition Market to Enhance Patient Outcomes and Feeding Efficiency • North America was the largest region in 2025.

What Is Covered Under Clinical Nutrition Market?

Clinical nutrition refers to a field of study that focuses on the prevention, diagnosis, and treatment of nutritional and metabolic abnormalities linked to acute and chronic illnesses, as well as disorders brought on by an imbalance of nutrients and energy. Clinical nutrition focuses on determining if a person is getting enough nutrients and providing their body with the proper kind of nourishment for overall health. The main types of products in clinical nutrition are infant nutrition, parental nutrition, and enteral nutrition. Infant nutrition is tailored to fulfil the unique needs of infants and toddlers, as well as to provide them with a good start in life. The different routes of administration include oral, enteral, and parenteral and are used in cancer, neurological diseases, gastrointestinal disorders, metabolic disorders, and others. It is used by pediatricians, adults, and geriatricians.

What Is The Clinical Nutrition Market Growth Forecast?

The clinical nutrition market size is expected to see strong growth in the next few years. It will grow to $102.42 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to development of disease-specific and personalized nutrition formulas, expansion of home care and tele-nutrition services, increasing adoption of digital monitoring tools, rising geriatric and pediatric population, growing government and private initiatives for clinical nutrition. Major trends in the forecast period include rising demand for infant nutrition products and specialized formulas, increasing adoption of parenteral and enteral nutrition in hospitals, growth in disease-specific nutritional therapies for cancer and metabolic disorders, expansion of geriatric and adult clinical nutrition programs, integration of home care and remote nutritional monitoring services.

What Is The Driver Of The Clinical Nutrition Market?

The rising geriatric population is anticipated to boost the growth of the clinical nutrition market going forward. The geriatric population refers to the group of people who are aged 65 years and older, often considered at higher risk for age-related health conditions and requiring specialized medical care. The geriatric population is rising due to increased life expectancy, as improvements in healthcare and living conditions allow more people to live longer than previous generations. Clinical nutrition helps the geriatric population by providing tailored dietary support that maintains health, prevents malnutrition, and manages age-related medical conditions. For instance, in October 2025, according to the Office for the National Statistics, a UK-based largest independent producer of official statistics, there were 625,000 people aged 90 or over in the UK in 2024, up from 612,000 in mid-2023 a 2.2% increase. Therefore, the growing geriatric population is anticipated to drive clinical nutrition industry growth.

Key Players In The Global Clinical Nutrition Market

Major companies operating in the clinical nutrition market are Abbott Laboratories, Nestlé S.A., Baxter Healthcare Ltd., B. Braun Melsungen AG, Perrigo Company plc, Fresenius Kabi AG, Danone S.A., Pfizer Inc., Mead Johnson Nutrition Company, Hero Nutritionals, Gentiva Health Services Inc., H.J. Heinz Company, Ajinomoto Co. Inc., Lonza Group Ltd., GlaxoSmithKline plc, BASF SE, Kendal Nutricare, DuPont Nutrition & Health, American HomePatient, Reckitt Benckiser Group plc, Vivante Health

Global Clinical Nutrition Market Trends and Insights

Major companies operating in the clinical nutrition market are increasingly focusing on technological advancements, such as semi‑solid enteral nutrition formulations, to meet the rising demand for more patient‑friendly, efficient, and physiologically compatible feeding options especially among patients with impaired oral intake or reduced energy needs. Semi‑solid nutrition products are specially designed to have a more gel‑like consistency than traditional liquid feeding formulas, which helps reduce the risk of reflux, allows slower gastric emptying, and improves tolerance in patients who receive enteral feeding via a tube, compared with standard low-viscosity liquid formulas. For instance, in January 2025, Otsuka Pharmaceutical Factory Inc., a Japan‑based clinical nutrition company, launched ENOSOLID Semi Solid for Enteral Use, a prescription semi-solid formula containing essential macronutrients, vitamins, trace elements, L-carnitine (for energy metabolism), and inulin (a soluble dietary fiber) developed for patients requiring lower maintenance energy; it is administered via gastric tube, is designed to minimize reflux, and supports adequate nutrient delivery even in small volumes. This innovation responds to growing demand for tailored nutritional therapies in post‑operative, elderly, or debilitated patient populations who benefit from a more physiologically congruent, easy‑to-manage enteral feed.

What Are Latest Mergers And Acquisitions In The Clinical Nutrition Market?

In May 2025, Danone S.A., a France‑based provider of food products and specialized clinical nutrition, acquired a majority stake in Kate Farms Inc., for an undisclosed amount. With this acquisition, Danone aims to expand its U.S. medical nutrition business by integrating Kate Farms’ plant‑based and organic nutrition solutions, thereby broadening its reach in both clinical and daily nutrition markets. Kate Farms Inc. is a US-based company that produces plant‑based, organic medical nutrition shakes and formulas for patients with specific health and feeding needs.

What Defines the Clinical Nutrition Market?

The clinical nutrition market includes revenues earned by entities by managing nutritional changes in patients linked to chronic diseases and by understanding the needs of individuals and groups for energy and nutrients. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Clinical Nutrition Market Report 2026?

The clinical nutrition market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the clinical nutrition industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.